NOWINY LEKARSKIE 4 - Nowiny Lekarskie - UMP

381Proteazy cysteinowe oraz ich autogenne inhibitory w chorobach nowotworowychB and cysteine proteinase inhibitors in human lung cancercell lines. Clin. Exp. Metastasis, 1997, 15, 368–381.9. Barrett A.J.: Fluorometric assay for cathepsin B and H withmethylcoumarylamide substrates. Biochemistry, 1980, 187,909–912.10. Barrett A.J., Kirschke H.: Cathepsin B, cathepsin H and cathepsinL. Methods. Enzymol., 1981, 80, 535–561.11. Bohley P., Seglen PO. Protheases and proteolysis in the lysosome.Experientia, 1992, 48, 151–157.12. Pagano M., Capony F., Rochefort. Pro-cathepsin D can activatein vitro procathepsin B cecreted by ovarian cancers. C.R. Acad. Sci., II309, 7–12.13. Siewiński M.: Method of purification of urinary thiol proteinaseinhibitors (UTPI) from human urine. Cancer Biochem.Biophys., 1991, 12, 33–44.14. Siewiński M., Kręcicki T., Jarmułowicz J. et al.: Cysteineproteinase inhibitors in serum of patients with head and necktumors. Diagnostic Oncology 1993: Proceedings Third InternationalConference on Head and Neck Cancer. San Francisco,July 26–30, 1992, 247.15. Minakata K., Asano M., Sato T., Harada N.: Assay of α-cysteine protinase inhibitor in serum or plasma. Hoppe – Seyler’s.Z. Physiol. Chem., 1982, 363, 493–498.16. Siewiński M., Saleh J., Gryboś M. Et al. Determination ofcysteine peptidases-like activity and their inhibitors in the serumof patients with ovarian cancer treated by conventionalchemotherapy and vitamin E. J. Exp. Ther. Oncol., 2004, 4,189–193.17. Swan S.K.: The search continues – an ideal marker of GFR[Editorial]. Clin. Chem., 1997, 43, 913–914.18. Stowe H., Lawrence D., Newman D.J. et al.: Anatylical Performanceof o Particle-enhanced Nephelometric Immunoassayfor Serum Cystatin C using Rate Analysis. Clin. Chem.,2001, 47, 1482–1485.19. Levicar N., Strojnik T., Kos J. et al.: Lysosomal enzymes, cathepsinsin brain tumor invasion. J. Neurosurgery, 2001, 48,3, 598–605.20. Saleh J., Siewiński M., Sebzda T. et al.: Inhibition f cathepsinB activity in human breast cancer tissue by cysteine peptidaseinhibitor isolated from human placenta:immunohistochemicaland biochemical studies. Folia Histochem. Cytobiol., 2003, 3,161–167.21. Utsunomiya T., Hara Y., Kataoka A. et al.: Cystatin-like metastasisassociated protein mRNA expression in human colorectalcancer is associated with both liver metastasis and patientsurvival. Clin. Cancer. Res., 2002, 8, 8, 2591–2594.22. Konduri S.D., Yanamandra N., Siddique K. et al. : Modulationof cystatin C expression impairs the invasive and tumorigenicpotential of human glioblastoma cells. Oncogene,2002, 21, 57, 8705–8712.Adres do korespondencji:Lek. med. Agnieszka WyrwińskaKatedra Chemii i Biochemii Klinicznej AMUl. Grunwaldzka 660-780 Poznańtel. (061) 8546590fax. (061) 8546599